Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edarbi in essential hypertension
NCT00695955Phase 3Completed
- Sponsor
- Takeda
- Start
- Jun 2007
- Primary completion
- May 2010
- Countries
- 3
01
Overview
A Phase 3 trial of azilsartan medoxomil in essential hypertension, sponsored by Takeda. Started Jun 2007; status: completed.
02
Drugs
azilsartan medoxomil
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00695955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00695955.